DDX41 and Alzheimer disease: In the same preclinical in-vitro AD-models a trio of proinflammatory cytokines—i.e., IL-1β, TNF-α, and IFN-γ—did not increase the rate of de novo Aβs synthesis but only expedited their release from the human neural cells [33].